Consequences of false-positive screening mammograms

JAMA Internal Medicine

Volumn 174, Issue 6, 2014, Pages 954-961

  Tosteson, Anna N A ^a   Fryback, Dennis G ^b   Hammond, Cristina S ^a   Hanna, Lucy G ^c   Grove, Margaret R ^a   Brown, Mary ^d   Wang, Qianfei ^a   Lindfors, Karen ^e   Pisano, Etta D ^f  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER SCREENING; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; MAMMOGRAPHY; PATIENT REFERRAL; PRIORITY JOURNAL; QUALITY OF LIFE; STATE TRAIT ANXIETY INVENTORY; TELEPHONE INTERVIEW;

AGED; ANXIETY; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; QUALITY OF LIFE;

EID: 84902151860     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.981     Document Type: Article

References (39)

1. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338(16):1089-1096. (Pubitemid 28227478)
2. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, ZhuW, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155(8):481-492.
3. Schwartz LM,Woloshin S, Sox HC, Fischhoff B, Welch HG. US women?s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000;320(7250):1635-1640. (Pubitemid 30364633)
4. US Preventive Services Task Force. Draft research plan: screening for breast cancer. http://www.uspreventiveservicestaskforce.org/uspstf14/ breastcancer/breastcandraftresplan.htm. Published 2013. Accessed November 17, 2013.
5. Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der Kamp LJ. False-positive findings in mammography screening induces short-term distress-breast cancer-specific concern prevails longer. Eur J Cancer. 2000;36(9):1089-1097. (Pubitemid 30330906)
6. Barton MB, Moore S, Polk S, Shtatland E, Elmore JG, Fletcher SW. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med. 2001;16(3):150-156. (Pubitemid 34208868)
7. Barton MB, Morley DS, Moore S, et al. Decreasing women?s anxieties after abnormal mammograms: a controlled trial. J Natl Cancer Inst. 2004;96(7): 529-538. (Pubitemid 38559577)
8. Brett J, Austoker J.Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med. 2001;23(4):292-300. (Pubitemid 34087292)
9. Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? a multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health Med. 1998;20(4):396-403. (Pubitemid 29017247)
10. Brett J, Bankhead C, Henderson B,Watson E, Austoker J. The psychological impact of mammographic screening: a systematic review. Psychooncology. 2005;14(11):917-938. (Pubitemid 41701209)
11. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007;146(7):502-510. (Pubitemid 351650559)
12. Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term consequences of false-positive screening mammography. J Med Screen. 2004;11(1):39-44. (Pubitemid 38365694)
13. Burman ML, Taplin SH, Herta DF, Elmore JG. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Ann Intern Med. 1999;131(1):1-6. (Pubitemid 29310010)
14. Castells X, Molins E, Macià F. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme. J Epidemiol Community Health. 2006;60(4):316-321.
15. Christiansen CL,Wang F, Barton MB, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst. 2000;92(20): 1657-1666.
16. Currence BV, Pisano ED, Earp JA, et al. Does biopsy, aspiration or six-month follow-up of a false-positive mammogram reduce future screening or have large psychosocial effects? Acad Radiol. 2003;10(11):1257-1266. (Pubitemid 37351898)
17. Sickles EA. False positive rate of screening mammography. N Engl J Med. 1998;339(8):561-562, author reply 563.
18. Sickles EA. Successful methods to reduce false-positive mammography interpretations. Radiol Clin North Am. 2000;38(4):693-700. (Pubitemid 30640059)
19. Tobias IS, Baum M. False positive findings of mammography will have psychological consequences [letter]. BMJ. 1996;312(7040):1227. (Pubitemid 26136721)
20. Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303(2):164-165.
21. Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann FamMed. 2013;11(2): 106-115.
22. Bond M, Pavey T,Welch K, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess. 2013;17(13):1-170, v-vi.
23. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology. 2010;19(10):1026-1034.
24. GoldM, Siegel J, Russell L, et al, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
25. Cole EB, Pisano ED, Kistner EO, et al. Diagnostic accuracy of digital mammography in patients with dense breasts who underwent problem-solving mammography: effects of image processing and lesion type. Radiology. 2003;226(1):153-160. (Pubitemid 36163923)
26. Hendrick RE, Lewin JM, D'Orsi C, et al. Non-inferiority study of ffdm in an enriched diagnostic cohort: comparison with screen-film mammography in 625 women. In: Yaffe M, ed. InternationalWorkshop on Digital Mammography 2000: 5th InternationalWorkshop on Digital Mammography. Madison, WI: Medical Physics; 2001:475-481.
27. Lewin JM, D?Orsi CJ, Hendrick RE, et al. Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer. AJR AmJ Roentgenol. 2002;179(3):671-677. (Pubitemid 34919579)
28. Skaane P, Skjennald A. Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program-the Oslo II Study. Radiology. 2004;232(1):197-204. (Pubitemid 38787838)
29. Skaane P, Young K, Skjennald A. Population-based mammography screening: comparison of screen-film and full-field digital mammography with soft-copy reading-Oslo I study. Radiology. 2003;229(3):877-884. (Pubitemid 37467596)
30. Pisano ED, Gatsonis CA, YaffeMJ, et al. American College of Radiology Imaging Network digital mammographic imaging screening trial: objectives and methodology. Radiology. 2005;236 (2):404-412. (Pubitemid 41023419)
31. Tosteson AN, Stout NK, Fryback DG, et al; DMIST Investigators. Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med. 2008;148(1):1-10. (Pubitemid 351664941)
32. Pisano ED, Gatsonis C, Hendrick E, et al; Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773-1783. (Pubitemid 41549889)
33. Pisano ED, Hendrick RE, YaffeMJ, et al; DMIST Investigators Group. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 2008;246(2):376-383.
34. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
35. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31(pt 3):301-306.
36. Kind P. The EuroQol instrument: an index ofhealth-related quality of life. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1996.
37. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005; 43(3):203-220. (Pubitemid 40353904)
38. Swan JS, Fryback DG, Lawrence WF, Sainfort F, Hagenauer ME, Heisey DM. A time-tradeoffmethod for cost-effectiveness models applied to radiology. Med Decis Making. 2000;20(1):79-88. (Pubitemid 30036266)
39. Schwartz LM,Woloshin S, Fowler FJ Jr,Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78. (Pubitemid 38040537)